Genmed Holding Corp., GENM.OB, is an international US and Holland based company, focusing on the delivery of low cost generic medicines directly to distribution chains in Europe and other countries.
The Company has entered into a production facility agreement with Atabay. Atabay was founded in 1939 and is one of the world’s leading manufacturers in fine chemicals and generic medicines.
The FDA and EMEA approved facility is fully operational and could produce drugs in large quantities.
Genmed is planning to distribute cheaper and safer FDA and EMEA approved generic medicines within Europe and other parts of the world.
The company is planning to expand its operations in Europe and the Middle East. Government run health care systems are facing massive budget cuts, this presents a huge opportunity for a nimble Pharmaceutical company. Genmed could get a firm foothold and benefit from the huge state supported health sector through out Europe and the Middle East. OxB02272011©
Disclaimer: We/our channel partners/affiliates have been compensated by the company directly or by a the third party shareholders. Therefore, our views and opinions of this company and/or any other company we profile or comment on are to be considered biased. Always seek expert investment advise before investing. It's YOUR money - Invest WISELY
No comments:
Post a Comment